This Week at the FDA: New CDER Director, End of the Shutdown, and MoreNovember 14, 2025November 20, 2025
This Week at FDA: Tidmarsh Saga Unfolds, Another Batch of Commissioner’s Vouchers, and MoreNovember 7, 2025November 10, 2025
This Week at FDA: New Guidance, Shutdown Pay Issues, and Another Inspection OverhaulOctober 24, 2025October 25, 2025
This Week at FDA: Lawmakers Look to Fund FDA, HHS’ Shutdown RIF, and MoreOctober 16, 2025October 18, 2025
This Week at FDA: More Layoffs at HHS, Prasad’s CBER Hires, and Peter Marks Joins Eli LillyOctober 10, 2025October 14, 2025
This Week at FDA: ANDA Prioritization Pilot, CDRH Guidance Priorities, and MoreOctober 3, 2025October 4, 2025
This Week: FDA Revokes LDT Rule, Monarez Warns About Vaccine Policies, Kennedy Called to Defend His DecisionsSeptember 19, 2025September 19, 2025
This Week at FDA: FDA’s Ad Crackdown, Abandoning AdComms, and MoreSeptember 12, 2025September 15, 2025